Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05296239 · ClinicalTrials.gov registry record · NA
SimpleC Wellness Platform With Social Robot Interaction
A NA study of Aging and Mild Cognitive Impairment, sponsored by SimpleC.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 2
- Study locations
NCT05296239: Completed NA study of Aging and Mild Cognitive Impairment, sponsored by SimpleC.
NCT05296239 is a NA study of Aging and Mild Cognitive Impairment that has completed, run by SimpleC. The registered enrollment target is 26 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05296239, a NA study of Aging and Mild Cognitive Impairment, has completed, sponsored by SimpleC.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 2
- Study locations
Study Summary
This implementation study will be conducted to test a Socially-Assistive Robot (SAR) system for residents in an Assisted Living environment. The goal of the SAR system is to enhance social engagement and connectedness. The system engages residents via robot-facilitated activities such as trivia and reminder and is integrated with the SimpleC Wellness Platform.
Primary Outcome
\[Interview\] Identified factors that facilitate successful implementation (e.g., WiFi, environmental set up, user perceptions) as derived from analysis of interview. A content analysis of the qualitative data was conducted. This identified themes, such as usefulness or engagement. We report the frequency of each theme mentioned during the interview.
Conditions Studied
Interventions
- OTHER SimpleC Wellness Platform with Social Robot Interaction
Study Locations (2)
Georgia
- University of Georgia - Athens
- SimpleC, LLC - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2022-02-03 |
| Est. Completion | 2022-03-07 |
| Phase | NA |
What the finished NCT05296239 record still lists
NCT05296239 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower).
The record links to 7 conditions, with Aging appearing as the primary indexed condition, and to 1 intervention - of which SimpleC Wellness Platform with Social Robot Interaction is the first listed.
NCT05296239 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05296239 about?
NCT05296239 is a clinical study titled "SimpleC Wellness Platform With Social Robot Interaction". This implementation study will be conducted to test a Socially-Assistive Robot (SAR) system for residents in an Assisted Living environment. The goal of the SAR system is to enhance social engagement and connectedness. The system engages residents via robot-facilitated activities such as trivia and ...
What is the current status of trial NCT05296239?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2022-02-03. Estimated completion is 2022-03-07.
What conditions does trial NCT05296239 study?
This clinical trial studies the following conditions: Aging, Mild Cognitive Impairment, Dementia, Quality of Life, Cognitive Impairment.
What interventions are being tested in trial NCT05296239?
The interventions under investigation include: SimpleC Wellness Platform with Social Robot Interaction (OTHER).
Who is sponsoring clinical trial NCT05296239?
This trial is sponsored by SimpleC, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05296239 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05296239's enrollment target sits among peer trials
26 210th of 262 higher than 51 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI